January 9, 2017: Huron Consulting Group formed a doji today, in oversold territory, on news it acquired Pope Woodhead & Associates. Huron Consulting Group says that it has expanded its life sciences strategy expertise with the acquisition of Pope Woodhead & Associates. The UK-based consulting firm provides market access capabilities to assist clients in developing value propositions for innovative medicines and technologies. The acquisition strengthens the firms ability to lead clients through complex payer and regulatory environments across the global healthcare community.
Pope Woodhead, based in Cambridge, England, partners with the top global pharmaceutical companies as well as biotech and medical device organizations to bring to market therapies that improve patients health. The firms knowledge of global, regional and local markets and deep understanding of the value of their clients innovations have made them a preferred partner of many life sciences organizations.
For reporting purposes, Pope Woodhead will be included in Hurons Education and Life Sciences operating segment. Terms of the stock purchase transaction were not disclosed.
Huron Consulting Group Stock Chart
The Finviz screener settings used to find Huron Consulting Group are: P/E Low (<15), Forward P/E Low (<15), EPS growth this year High (>25%), EPS growth past 5 years High (>25%), RSI (14) Oversold (40), Candlestick Doji
Huron Consulting Group helps clients in diverse industries improve performance, transform the enterprise, reduce costs, leverage technology, process and review large amounts of complex data, address regulatory changes, recover from distress and stimulate growth.